CAM
BHVN

Cresset Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Cresset Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,305
Closed -$511K – 1117
2022
Q1 		$511K Sell
4,305
-787
-15% -$93.4K 0.01% 602
2021
Q4 		$702K Buy
5,092
+568
+13% +$78.3K 0.01% 576
2021
Q3 		$628K Sell
4,524
-2
-0% -$278 0.01% 538
2021
Q2 		$439K Buy
+4,526
New +$439K 0.01% 607